I can't belive the big jump for the last month is from the trial completion which was a given. The Army will want the stuff after the data is out but that won't be for 2-3 months. So I really don't know. My speculation is when Dr. Moore (who has the most patients enrolled in the trial and is not blinded to his own instiution results) on 20/20 said unequivocally that Polyheme was better than blood may have generated interest. The 1 million plus shares traded today is a big uptick in volume so someone is definitely buying.
Market Data 
Markets 
AI
